Skip to main content
. Author manuscript; available in PMC: 2016 May 3.
Published in final edited form as: N Engl J Med. 2009 May 21;360(21):2252–2256.

Table 1.

Association between Phenotypes of Age-Related Macular Degeneration and the TLR3 Variant rs3775291 (Leu412Phe).*

Value Edwards Series Swaroop Series Seddon Series AREDS Series
Patients with
Geographic
Atrophy
Patients with
Exudative
AMD
Controls Patients with
Geographic
Atrophy
Patients with
Exudative
AMD
Controls Patients with
Geographic
Atrophy
Patients with
Exudative
AMD
Controls Patients with
Geographic
Atrophy
Patients with
Exudative
AMD
Controls
No. of participants 89 178 222 279 377 317 218 646 479 184 247 171

Genotype — no. (%)

  CC 42 (47) 73 (41) 124 (56) 135 (48) 171 (45) 158 (50) 113 (52) 305 (47) 235 (49) 86 (47) 117 (47) 81 (47)

  CT 41 (46) 88 (49) 81 (36) 120 (43) 171 (45) 124 (39) 78 (36) 304 (47) 210 (44) 82 (45) 108 (44) 78 (46)

  TT 6 (7) 17 (10) 17 (8) 24 (9) 35 (9) 35 (11) 27 (12) 37 (6) 34 (7) 16 (9) 22 (9) 12 (7)

Frequency of minor T allele 0.30 0.34 0.26 0.30 0.32 0.31 0.30 0.29 0.29 0.31 0.31 0.30

P value

  Allele 0.33 0.01 0.86 0.58 0.68 0.94 0.74 0.76

  Additive genotype 0.33 0.01 0.86 0.59 0.63 0.90 0.73 0.77
*

The TaqMan genotyping platform was used for the Edwards and Swaroop series, the Affymetrix 6.0 genotyping platform for the Seddon series, and the Illumina Human-1 genotyping platform for the Age-Related Eye Disease Study (AREDS). AMD denotes age-related macular degeneration. P values are for comparisons with controls with the use of an additive model of genotype effect on the risk of AMD.

Data are from the National Institutes of Health Genotype and Phenotype database (dbGaP) (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000001.v2.p1; accession number, phs000001.v2.p1).